Treatments & Clinical Trials

How patient-derived stem cells enable disease modeling, drug testing, gene editing and regenerative therapies—and why newborn stem cell banking matters.

How newborn stem cell banking, MSCs and exosome therapies repair tissues, reduce inflammation, and target age-related diseases like arthritis, Alzheimer's, and heart failure.

Overview of MSC and HSCT advances, gene editing and CAR technologies, clinical trial progress, risks, and cell banking for future autoimmune treatments.

How umbilical cord blood stem cells and exosomes support heart repair, summarize clinical findings, and explain cord blood banking benefits.

Umbilical cord stem cells support heart repair via regeneration, angiogenesis, and immune modulation; covers delivery methods and the role of stem cell banking.

Exosomes from stem cells offer a safer, cell-free way to speed wound repair, reduce inflammation, and boost angiogenesis, with evolving delivery and storage options.

Compare MSC injections for knee osteoarthritis: early-stage treatment preserves cartilage and gives longer pain relief; late-stage use focuses on symptom control and delaying surgery.

How umbilical cord mesenchymal stem cells combat aging, support skin, brain and joint repair, and why cord/exosome banking matters.

Overview of how cord blood stem cells and exosomes aid heart repair—mechanisms, clinical evidence, delivery challenges, and future therapies.